Silicon Biosystems Spa

Menarini Silicon Biosystems is a company that specializes in the development and commercialization of technologies for the detection and analysis of rare cells, such as circulating tumor cells (CTCs). The company's core products include the CELLSEARCH system, which is a platform for enumerating CTCs in blood samples, and the CellMag product line, which is a manual immunomagnetic enrichment and staining system for CTCs. The company also offers lab services, including custom assays and single-cell analysis, to support research and clinical trials in oncology and other fields. Additionally, Menarini Silicon Biosystems has developed a non-invasive liquid biopsy assay for monitoring multiple myeloma disease status, which can be used to track disease progression and response to treatment. The company's technologies and services are designed to support the development of personalized medicine and to improve patient outcomes in cancer and other diseases.

We aspire to improve people’s lives significantly through unique innovation in cell biology integrated with lab-on-a-chip technology. Our mission is to enhance our customers’ diagnostic and therapy design capabilities when addressing unmet medical needs.

Silicon Biosystems has developed a set of proprietary solutions called lab-on-a-chip technologies, targeted at miniaturized cell-biology testing. Silicon Biosystems exploits the microelectronics potential in order to produce miniaturized cellular biology laboratories. The approach patented by Silicon Biosystems has given rise to an unprecedented technology platform able to perform complex protocols, since it offers the unique possibility of controlling individual cells and micro-particles inside a micro-chamber. Silicon Biosystems technology individually manages more than 100,000 cells on a single microelectronic chip, using software control and incorporating sensors to detect the results of complex procedures. The company has a reputation for being one of the most innovative start-ups in the field of “lab-on-a-chip” based on active substrates, as testified by a number of awards and recognitions. Silicon Biosystems is also an industrial member of the nano2Life EC Network of Excellence on nanobiotechnologies.